Echo Street Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-49,073
| Closed | -$495K | – | 529 |
|
|
2022
Q4 | $495K | Buy |
49,073
+12,715
| +35% | +$128K | ﹤0.01% | 283 |
|
|
2022
Q3 | $815K | Buy |
+36,358
| New | +$815K | 0.01% | 185 |
|
|
2021
Q3 | – | Sell |
-2,865
| Closed | -$249K | – | 668 |
|
|
2021
Q2 | $249K | Sell |
2,865
-1,756
| -38% | -$153K | ﹤0.01% | 517 |
|
|
2021
Q1 | $381K | Buy |
+4,621
| New | +$381K | ﹤0.01% | 371 |
|